Status:
UNKNOWN
TCA Peel and Photobiomodulation for Hand Rejuvenation
Lead Sponsor:
University of Nove de Julho
Conditions:
Skin Aging
Eligibility:
All Genders
40-70 years
Phase:
PHASE2
Brief Summary
Photodamage is a growing concern in contemporary society because promotes early skin aging and different pathologies resulting from prolonged and repeated exposure to ultraviolet solar radiation, whic...
Detailed Description
Participants will be divided into two groups for the treatment of photoaging of hands: (A) Group 20% TCM + PBM: Application of chemical peel of 20% trichloroacetic acid solution in association with p...
Eligibility Criteria
Inclusion
- Individuals without comorbidities or with controlled comorbidities (ASA I and ASA II physical status classification).
- Participants must also have skin phototype I, II or III according to the Fitzpatrick classification.
Exclusion
- Smoking, alcoholic, oncological, malnourished, anemic, pregnant, immunosuppressed participants.
- Patients with blood dyscrasias, psychiatric illnesses, collagen diseases (even with proper control), photosensitivity, individuals undergoing chemotherapy or hormone therapy and with scar changes (keloids and hypertrophic scar).
- Also excluded from the study are individuals who performed previous aesthetic procedures on their hands and use of medications that influence skin color, such as amiodarone, tetracyclines, tricyclic antidepressants, phenothiazines and others.
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2022
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04485091
Start Date
October 1 2021
End Date
February 28 2022
Last Update
September 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Nove de Julho (UNINOVE)
São Paulo, Brazil, 01504-001